NEW YORK (GenomeWeb News) – Clinical-stage biopharmaceutical company Sequella said yesterday that it has received a $244,000 grant from the National Institute of Allergy and Infectious Diseases to develop a diagnostic assay that will use nucleic acid amplification to test for drug-resistant Mycobacterium tuberculosis.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.